Lactobacillus paracasei GMNL-32, Lactobacillus reuteri GMNL-89 and L. reuteri GMNL-263 ameliorate hepatic injuries in lupus-prone mice

British Journal of Nutrition

Volumn 117, Issue 8, 2017, Pages 1066-1074

  Hsu, Tsai Ching ^a,b   Huang, Chih Yang ^c,d   Liu, Chung Hsien ^a   Hsu, Kuo Ching ^a   Chen, Yi Hsing ^e,f   Tzang, Bor Show ^a,b  

^a CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^b CHUNG SHAN MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d ASIA UNIVERSITY   (Taiwan)

^e Research and Development Department   (Taiwan)

^f NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

Author keywords

Lactobacillus paracasei GMNL 32; Lactobacillus reuteri GMNL 263; Lactobacillus reuteri GMNL 89; Liver disorders; Probiotics; Systemic lupus erythematosus

Indexed keywords

BETA ACTIN; C REACTIVE PROTEIN; CASPASE 3; GELATINASE A; GELATINASE B; I KAPPA B KINASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROBIOTIC AGENT; STRESS ACTIVATED PROTEIN KINASE; SYNAPTOPHYSIN; TUMOR NECROSIS FACTOR; CYTOKINE; NITRIC OXIDE SYNTHASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; LACTOBACILLUS PARACASEI; LACTOBACILLUS PARACASEI GMNL 32; LACTOBACILLUS REUTERI; LACTOBACILLUS REUTERI GMNL 263; LACTOBACILLUS REUTERI GMNL 89; LIVER INJURY; LYMPHOCYTIC INFILTRATION; MOUSE; NONHUMAN; PROTEIN CLEAVAGE; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ANIMAL; CLASSIFICATION; COMPLICATION; GENE EXPRESSION REGULATION; GENETICS; LIVER CELL; LIVER DISEASES; METABOLISM; MICROBIOLOGY; NEW ZEALAND BLACK MOUSE; PHYSIOLOGY; RANDOMIZATION;

ANIMALS; APOPTOSIS; C-REACTIVE PROTEIN; CYTOKINES; FEMALE; GENE EXPRESSION REGULATION; HEPATOCYTES; LACTOBACILLUS PARACASEI; LACTOBACILLUS REUTERI; LIVER DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED NZB; NITRIC OXIDE SYNTHASE; PROBIOTICS; RANDOM ALLOCATION; SIGNAL TRANSDUCTION;

EID: 85019240726     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114517001039     Document Type: Article

References (37)

1. Gerritsen J, Smidt H, Rijkers GT, et al. (2011) Intestinal microbiota in human health and disease: the impact of probiotics. Genes Nutr 6, 209-240
2. Dwivedi M, Kumar P, Laddha NC, et al. (2016) Induction of regulatory T cells: a role for probiotics and prebiotics to suppress autoimmunity. Autoimmun Rev 15, 379-392
3. Nagpal R, Kumar A, Kumar M, et al. (2012) Probiotics, their health benefits and applications for developing healthier foods: a review. FEMS Microbiol Lett 334, 1-15
4. Govender M, Choonara YE, Kumar P, et al. (2014) A review of the advancements in probiotic delivery: conventional vs. nonconventional formulations for intestinal flora supplementation. AAPS PharmSciTech 15, 29-43
5. Matsuzaki T, Nagata Y, Kado S, et al. (1997) Effect of oral administration of Lactobacillus casei on alloxan-induced diabetes in mice. APMIS 105, 637-642
6. Kaur IP, Chopra K &Saini A (2002) Probiotics: potential pharmaceutical applications. Eur J Pharm Sci 15, 1-9
7. Moreno LeBlanc A, Matar C &Perdigon G (2007) The application of probiotics in cancer. Br J Nutr 98, Suppl. 1, S105-S110
8. Laitinen K, Poussa T, Isolauri E, et al. (2009) Probiotics and dietary counselling contribute to glucose regulation during and after pregnancy a randomised controlled trial. Br J Nutr 101, 1679-1687
9. Shida K, Nanno M &Nagata S (2011) Flexible cytokine production by macrophages and T cells in response to probiotic bacteria: a possible mechanism by which probiotics exert multifunctional immune regulatory activities. Gut Microbes 2, 109-114
10. Villena J &Kitazawa H (2014) Modulation of intestinal TLR4-inflammatory signaling pathways by probiotic microorganisms: lessons learned from Lactobacillus jensenii TL2937. Front Immunol 4, 512
11. Wang Y, Xie J, Li Y, et al. (2016) Probiotic Lactobacillus casei Zhang reduces pro-inflammatory cytokine production and hepatic inflammation in a rat model of acute liver failure. Eur J Nutr 55, 821-831
12. Hahn BH (1993) An overview of the pathogenesis of systemic lupus erythematosus. In Dubois' Lupus Erythematosus, pp. 69-76 [DJ Wallace and BH Hahn, editors]. Philadelphia, PA: Williams and Wilkins
13. Abraham S, Begum S &Isenberg D (2004) Hepatic manifestations of autoimmune rheumatic diseases. Ann Rheum Dis 63, 123-129
14. Lu MC, Li KJ, Hsieh SC, et al. (2006) Lupus-related advanced liver involvement as the initial presentation of systemic lupus erythematosus. J Microbiol Immunol Infect 39, 471-475
15. Grover S, Rastogi A, Singh J, et al. (2014) Spectrum of histomorphologic findings in liver in patients with SLE: a review. Hepat Res Treat 2014, 562979
16. Hsu TC, Huang CY, Chiang SY, et al. (2008) Transglutaminase inhibitor cystamine alleviates the abnormality in liver from NZB/W F1 mice. Eur J Pharmacol 579, 382-389
17. Tzang BS, Chiang SY, Lai WX, et al. (2008) Treatment with cystamine reduces apoptosis in liver from NZB/W F1 mice. Int Immunopharmacol 8, 589-596
18. Cuervo A, Hevia A, López P, et al. (2015) Association of polyphenols from oranges and apples with specific intestinal microorganisms in systemic lupus erythematosus patients. Nutrients 7, 1301-1317
19. Johnson BM, Gaudreau MC, Al-Gadban MM, et al. (2015) Impact of dietary deviation on disease progression and gut microbiome composition in lupus-prone SNF1 mice. Clin Exp Immunol 181, 323-337
20. Lo RS, Austin AS &Freeman JG. (2014) Is there a role for probiotics in liver disease? ScientificWorldJournal 2014, 874768
21. Paolella G, Mandato C, Pierri L, et al. (2014) Gut-liver axis and probiotics: their role in non-alcoholic fatty liver disease. World J Gastroenterol 20, 15518-15531
22. Ting WJ, Kuo WW, Hsieh DJ, et al. (2015) Heat killed Lactobacillus reuteri GMNL-263 reduces fibrosis effects on the liver and heart in high fat diet-hamsters via TGF-β suppression. Int J Mol Sci 16, 25881-25896
23. Hsieh FC, Lan CC, Huang TY, et al. (2016) Heat-killed and live Lactobacillus reuteri GMNL-263 exhibit similar effects on improving metabolic functions in high-fat diet-induced obese rats. Food Funct 7, 2374-2388
24. Liao PH, Kuo WW, Kuo CH, et al. (2016) Lactobacillus reuteri GMNL-263 reduces hyperlipidaemia and the heart failure process in high-calorie diet-fed induced heart dysfunction in rats. J Funct Foods 20, 226-235
25. Hsu TC, Chiu CC, Chang SC, et al. (2016) Human parvovirus B19 VP1u Protein as inflammatory mediators induces liver injury in naïve mice. Virulence 7, 110-118
26. Lin CJ, Chiu CC, Chen YC, et al. (2015) Taurine attenuates hepatic inflammation in chronic alcohol-fed rats through inhibition of TLR4/MyD88 signaling. J Med Food 18, 1291-1298
27. Hsu TC, Chiu CC, Lin HL, et al. (2015) Attenuated effects of deep-sea water on hepatic apoptosis in STZ-induced diabetic rats. Chin J Physiol 58, 197-205
28. Tzang BS, Lin TM, Tsai CC, et al. (2011) Increased cardiac injury in NZB/W F1 mice received antibody against human parvovirus B19 VP1 unique region protein. Mol Immunol 48, 1518-1524
29. Chiu CC, Shi YF, Yang JJ, et al. (2014) Effects of human Parvovirus B19 and Bocavirus VP1 unique region on tight junction of human airway epithelial A549 cells. PLOS ONE 9, e107970
30. Tian XP &Zhang X (2010) Gastrointestinal involvement in systemic lupus erythematosus: insight into pathogenesis, diagnosis and treatment. World J Gastroenterol 16, 2971-2977
31. Dongarrà ML, Rizzello V, Muccio L, et al. (2013) Mucosal immunology and probiotics. Curr Allergy Asthma Rep 13, 19-26
32. Honad K &Littman DR (2012) The microbiome in infectious disease and inflammation. Ann Rev Immunol 30, 758-795
33. Lescheid DW (2014) Probiotics as regulators of inflammation: a review. Funct Foods Health Dis 4, 299-311
34. Arthur JS &Ley SC (2013) Mitogen-activated protein kinases in innate immunity. Nat Rev Immunol 13, 679-692
35. Mavropoulos A, Orfanidou T, Liaskos C, et al. (2013) p38 MAPK signaling in pemphigus: implications for skin autoimmunity. Autoimmune Dis 2013, 728529
36. Gottschalk TA, Tsantikos E &Hibbs ML (2015) Pathogenic inflammation and its therapeutic targeting in systemic lupus erythematosus. Front Immunol 6, 550
37. Buyon JP, Cohen P, Merrill JT, et al. (2015) A highlight from the LUPUS 2014 meeting: eight great ideas. Lupus Sci Med 2, e000087